Entra Pharmaceuticals Receives Series A Financing
Friday, December 19, 2008 5:34:00 AM PDT | VentureDeal Staff
Waltham, Massachusetts -- Stealthy pharmaceutical company Entra Pharmaceuticals (no website) has garnered $4.23 million in its first round of venture capital investment, according to a report in PE Hub.
Not much is known about the company, however Entra is believed to be developing various drug delivery technologies.
Investors in the round included Flybridge Capital Partners and North Bridge Venture Partners. The company did not disclose how it would use the funding proceeds.
Email Page | Print Page